Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 8.06% | 164.18 | 0.0% | $3009.11m | |
| BNGO | BioNano Genomics, Inc. | -5.39% | 11.55 | 0.0% | $2382.24m | |
| GILD | Gilead Sciences, Inc. | -1.06% | 65.99 | 1.0% | $648.37m | |
| AMGN | Amgen, Inc. | -1.52% | 254.66 | 1.3% | $575.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -4.69% | 518.57 | 2.7% | $474.62m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.11% | 158.33 | 2.0% | $465.29m | |
| ILMN | Illumina, Inc. | 0.70% | 423.50 | 3.5% | $446.92m | |
| CRSP | CRISPR Therapeutics AG | -3.24% | 164.03 | 0.6% | $431.11m | |
| NVAX | Novavax, Inc. | 2.38% | 130.19 | 92.9% | $416.81m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -4.55% | 226.83 | 1.9% | $362.28m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.84% | 90.95 | 13.8% | $337.11m | |
| BNTX | BioNTech SE | 3.10% | 109.58 | 0.0% | $317.47m | |
| BIIB | Biogen, Inc. | -2.16% | 265.80 | 1.7% | $316.62m | |
| EXAS | EXACT Sciences Corp. | -2.26% | 137.85 | 19.6% | $245.97m | |
| SRNE | Sorrento Therapeutics, Inc. | 36.26% | 14.20 | 1.4% | $244.37m |
Company Profile
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.